Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
71.5M
-
Shares change
-
+244K
-
Total reported value, excl. options
-
$977M
-
Value change
-
-$9.87M
-
Put/Call ratio
-
0.42
-
Number of buys
-
72
-
Number of sells
-
-53
-
Price
-
$13.66
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q3 2022
167 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.5M shares
of 87M outstanding shares and own 82.24% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (6.64M shares), BlackRock Inc. (4.88M shares), STATE STREET CORP (4.37M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (4.06M shares), Avoro Capital Advisors LLC (3.53M shares), Holocene Advisors, LP (3.48M shares), VANGUARD GROUP INC (3.29M shares), BVF INC/IL (3.2M shares), Deep Track Capital, LP (3.19M shares), and T. Rowe Price Investment Management, Inc. (2.57M shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.